BioMarin Pharmaceutical I...
63.78
-3.21 (-4.79%)
At close: Jan 14, 2025, 3:59 PM
63.81
0.05%
After-hours Jan 14, 2025, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98
Revenue 2.42B 2.10B 1.85B 1.86B 1.70B 1.49B 1.31B 1.12B 889.89M 751.04M 548.49M 500.72M 441.36M 376.27M 324.66M 296.49M 121.58M 84.21M 25.67M 18.64M 12.10M 13.92M 11.70M 12.33M 6.98M 1.20M
Cost of Revenue 577.07M 483.67M 470.51M 524.27M 359.47M 315.26M 241.79M 209.62M 152.01M 129.76M 95.74M 91.83M 84.02M 70.28M 65.91M 52.51M 18.36M 8.74M 2.63M 3.95M n/a n/a n/a -6.61M -6.09M -700.00K
Gross Profit 1.84B 1.61B 1.38B 1.34B 1.34B 1.18B 1.07B 907.23M 737.89M 621.28M 452.74M 408.89M 357.33M 305.98M 258.75M 243.98M 103.22M 75.47M 23.04M 14.69M 12.10M 13.92M 11.70M 18.94M 13.07M 1.90M
Operating Income 194.44M 57.55M -60.01M -96.26M -125.46M -123.52M -14.70M -803.43M -110.70M -92.89M -156.01M -110.22M -33.89M 544.00K 16.43M 39.76M -57.29M -24.67M -64.21M -179.37M -75.80M -78.85M -51.95M -33.00M -27.50M -12.90M
Interest Income 58.34M 18.03M 10.48M 16.61M 22.75M 22.83M 14.85M 7.49M 4.50M 5.94M 3.08M 2.58M 2.93M 4.11M 5.09M 16.39M n/a 12.87M 1.86M n/a 2.56M n/a n/a 2.98M n/a n/a
Pretax Income 188.56M 149.58M -75.35M -42.32M -94.81M -142.71M -35.88M -831.05M -154.72M -124.87M -176.50M -118.28M -43.63M -21.49M 566.00K 33.42M -15.07M -28.53M -74.27M -187.44M -75.80M -77.46M -70.93M -40.34M -29.17M -12.30M
Net Income 167.65M 141.56M -64.08M 854.03M -23.85M -77.21M -117.04M -630.21M -171.80M -133.97M -176.35M -114.35M -53.84M 205.82M -488.00K 30.83M -15.80M -28.53M -74.27M -187.44M -75.80M -77.46M -67.61M -37.36M -28.07M -12.30M
Selling & General & Admin 937.30M 854.01M 759.38M 737.67M 680.92M 604.35M 554.34M 476.59M 402.27M 302.16M 235.36M 198.17M 175.42M 151.72M 124.29M 106.57M 77.54M 49.03M 41.56M 37.61M 14.40M 17.54M 6.72M 8.81M 6.80M 3.50M
Research & Development 746.77M 649.61M 628.79M 628.12M 715.01M 696.33M 610.75M 661.90M 634.81M 461.54M 354.78M 302.22M 214.37M 147.31M 115.12M 93.29M 78.60M 66.73M 56.39M 49.78M 54.81M 54.45M 45.28M 35.79M 27.21M 10.50M
Other Expenses n/a 67.19M 69.93M 66.66M 74.11M 2.21M 7.97M 4.93M -9.30M 279.00K 982.00K -1.79M 1.43M 6.41M 2.91M 4.37M 4.37M -15.62M -10.69M 75.21M 18.69M 9.55M n/a 7.33M 6.56M 800.00K
Operating Expenses 1.75B 1.57B 1.46B 1.43B 1.47B 1.35B 1.21B 1.11B 1.02B 781.67M 608.75M 519.11M 389.80M 299.03M 242.32M 204.23M 160.51M 100.14M 87.25M 162.60M 87.90M 81.54M 52.00M 51.94M 40.57M 14.80M
Interest Expense 17.34M 15.97M 15.34M 29.31M 23.46M 43.66M 42.71M 39.50M 38.24M 36.64M 10.45M 7.64M 8.35M 10.33M 14.09M 16.39M n/a 16.73M 11.92M n/a 3.13M n/a n/a 7.00K n/a n/a
Selling & Marketing Expenses 488.40M 450.30M 405.10M 403.40M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 2.27B 2.05B 1.93B 1.96B 1.83B 1.66B 1.45B 1.32B 1.17B 911.43M 704.49M 610.94M 473.82M 369.32M 308.23M 256.74M 178.87M 108.88M 89.88M 166.55M 87.90M 81.54M 52.00M 45.33M 34.48M 14.10M
Income Tax 20.92M 8.02M -11.27M -901.42M -70.96M -65.49M 81.17M -200.84M 17.07M 9.10M -150.00K -3.93M 10.21M -227.31M 1.05M 2.59M 729.00K 23.13M 21.89M 36.56M -5.00K 9.84M 19.97M 4.36M 573.00K -600.00K
Shares Outstanding (Basic) 187.83M 185.27M 182.85M 180.80M 179.04M 177.06M 174.43M 165.99M 160.03M 145.62M 137.75M 120.27M 112.12M 103.09M 100.27M 98.97M 95.88M 84.58M 68.83M 64.35M 62.13M 53.28M 41.08M 35.86M 29.94M 22.49M
Shares Outstanding (Diluted) 191.59M 188.96M 182.85M 191.68M 179.04M 177.27M 174.43M 166.22M 160.03M 146.35M 137.75M 120.27M 112.12M 125.67M 100.27M 103.57M 95.88M 84.58M 68.83M 64.35M 62.13M 53.28M 41.08M 35.86M 29.94M 22.49M
EPS (Basic) 0.89 0.76 -0.35 4.75 -0.13 -0.44 -0.67 -3.8 -1.07 -0.92 -1.28 -0.95 -0.48 1.99 -0.00 0.31 -0.16 -0.34 -1.08 -2.91 -1.22 -1.45 -1.65 -1.04 -0.94 -0.55
EPS (Diluted) 0.87 0.75 -0.35 4.53 -0.13 -0.44 -0.67 -3.79 -1.07 -0.92 -1.28 -0.95 -0.48 1.73 -0.00 0.29 -0.16 -0.34 -1.08 -2.91 -1.22 -1.45 -1.65 -1.04 -0.94 -0.55
EBITDA 310.28M 267.51M 48.03M -5.85M 33.95M -3.54M 94.76M -705.53M -110.70M -49.96M -137.36M -79.84M -172.00K 17.07M 35.63M 67.45M -57.29M -14.88M -54.47M -134.63M -66.36M -59.12M -40.63M -29.94M -20.38M -12.10M
Depreciation & Amortization 104.39M 101.97M 108.04M 105.88M 105.30M 95.50M 87.92M 86.03M -17.69M 17.97M 47.26M 18.72M 36.09M 27.74M 2.91M 4.37M 1.09M 11.96M 10.07M 13.28M 9.44M 8.50M 7.00M 7.33M 6.56M 800.00K